These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25871522)
1. Structural and functional characterization of tumor suppressors TIG3 and H-REV107. Wei H; Wang L; Ren X; Yu W; Lin J; Jin C; Xia B FEBS Lett; 2015 May; 589(11):1179-86. PubMed ID: 25871522 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Uyama T; Jin XH; Tsuboi K; Tonai T; Ueda N Biochim Biophys Acta; 2009 Dec; 1791(12):1114-24. PubMed ID: 19615464 [TBL] [Abstract][Full Text] [Related]
3. Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Han BG; Cho JW; Cho YD; Kim SY; Yoon HJ; Song HK; Cheong HK; Jeon YH; Lee DK; Lee S; Lee BI Protein Expr Purif; 2010 May; 71(1):103-7. PubMed ID: 20100577 [TBL] [Abstract][Full Text] [Related]
4. Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway. Han CW; Jeong MS; Jang SB Biochem Biophys Res Commun; 2017 Sep; 491(2):257-264. PubMed ID: 28743497 [TBL] [Abstract][Full Text] [Related]
5. 1H, 13C, and 15N resonance assignments of the N-terminal domain of human TIG3. Wang L; Yu W; Ren X; Lin J; Jin C; Xia B Biomol NMR Assign; 2012 Oct; 6(2):201-3. PubMed ID: 22290676 [TBL] [Abstract][Full Text] [Related]
6. Solution structure of the N-terminal catalytic domain of human H-REV107--a novel circular permutated NlpC/P60 domain. Ren X; Lin J; Jin C; Xia B FEBS Lett; 2010 Oct; 584(19):4222-6. PubMed ID: 20837014 [TBL] [Abstract][Full Text] [Related]
7. H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation. Tsai FM; Chen ML; Wang LK; Lee MC PLoS One; 2015; 10(9):e0138586. PubMed ID: 26381418 [TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. Uyama T; Morishita J; Jin XH; Okamoto Y; Tsuboi K; Ueda N J Lipid Res; 2009 Apr; 50(4):685-93. PubMed ID: 19047760 [TBL] [Abstract][Full Text] [Related]
9. 1H, 13C and 15N resonance assignments of human H-REV107 N-terminal domain. Ren X; Lin J; Jin C; Xia B Biomol NMR Assign; 2010 Oct; 4(2):175-8. PubMed ID: 20526701 [TBL] [Abstract][Full Text] [Related]
10. Regulation of peroxisomal lipid metabolism by catalytic activity of tumor suppressor H-rev107. Uyama T; Ichi I; Kono N; Inoue A; Tsuboi K; Jin XH; Araki N; Aoki J; Arai H; Ueda N J Biol Chem; 2012 Jan; 287(4):2706-18. PubMed ID: 22134920 [TBL] [Abstract][Full Text] [Related]
11. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642 [TBL] [Abstract][Full Text] [Related]
12. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway. Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338 [TBL] [Abstract][Full Text] [Related]
13. Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-terminal region is required for TIG3 function as a keratinocyte differentiation regulator. Jans R; Sturniolo MT; Eckert RL J Invest Dermatol; 2008 Mar; 128(3):517-29. PubMed ID: 17762858 [TBL] [Abstract][Full Text] [Related]
14. Interaction of Phospholipase A/Acyltransferase-3 with Pex19p: A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES. Uyama T; Kawai K; Kono N; Watanabe M; Tsuboi K; Inoue T; Araki N; Arai H; Ueda N J Biol Chem; 2015 Jul; 290(28):17520-34. PubMed ID: 26018079 [TBL] [Abstract][Full Text] [Related]
15. H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling. Nazarenko I; Kristiansen G; Fonfara S; Guenther R; Gieseler C; Kemmner W; Schafer R; Petersen I; Sers C Am J Pathol; 2006 Oct; 169(4):1427-39. PubMed ID: 17003497 [TBL] [Abstract][Full Text] [Related]
16. Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif. Scharadin TM; Adhikary G; Shaw K; Grun DJB; Xu W; Eckert RL J Invest Dermatol; 2014 May; 134(5):1220-1229. PubMed ID: 24401997 [TBL] [Abstract][Full Text] [Related]
17. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. Sers C; Emmenegger U; Husmann K; Bucher K; Andres AC; Schäfer R J Cell Biol; 1997 Feb; 136(4):935-44. PubMed ID: 9049257 [TBL] [Abstract][Full Text] [Related]
18. H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells. Shyu RY; Wu CC; Wang CH; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM J Biomed Sci; 2013 May; 20(1):30. PubMed ID: 23687991 [TBL] [Abstract][Full Text] [Related]
19. Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box. Roder K; Kim KH; Sul HS Biochem Biophys Res Commun; 2002 May; 294(1):63-70. PubMed ID: 12054741 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Husmann K; Sers C; Fietze E; Mincheva A; Lichter P; Schäfer R Oncogene; 1998 Sep; 17(10):1305-12. PubMed ID: 9771974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]